# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and raises the price target from $18 to $22.
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.21 ...
B of A Securities analyst Chase Mulvehill maintains Core Laboratories (NYSE:CLB) with a Underperform and lowers the price ta...
Piper Sandler analyst Luke Lemoine maintains Core Laboratories (NYSE:CLB) with a Neutral and lowers the price target from $1...
Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and raises the price target from $17 to $18.
Core Laboratories (NYSE:CLB) reported quarterly Adj earnings of $0.19 per share which beat the analyst consensus estimate of $0...
B of A Securities analyst Chase Mulvehill maintains Core Laboratories (NYSE:CLB) with a Underperform and lowers the price ta...